SCHEMBL4961765

SCHEMBL4961765

CCCCc1nc2ccccc2c(=O)n1-c1c(F)cc(N2CCOCC2)cc1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
MAPK1 P28482 1/20 0.54
ALDH1A1 P00352 5/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
HIF1A Q16665 1/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
ATM Q13315 1/20 0.45
MAPT P10636 2/20 0.45
GAA P10253 2/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4956887 0.89 LMNA (0.55) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4958853 0.89 ALDH1A1 (0.56) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4957364 0.87 LMNA (0.71) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4955931 0.82 ALDH1A1 (0.56) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4957056 0.81 LMNA (0.60) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4955926 0.81 MEN1 (0.55) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4961212 0.81 ALDH1A1 (0.52) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4959496 0.77 LMNA (0.73) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4958764 0.77 LMNA (0.71) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4957819 0.76 LMNA (0.71) LMNAMAPK1ALDH1A1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed